Pharmacokinetic interaction of gabapentin and naproxen in rats and humans.

被引：2
|
作者：
Feng, MR
Ouellet, D
Li, W
Berna, K
Ferreira, S
Knowlton, P
Fountain, S
Randinitis, E
Haig, G
Wesche, D
机构：
[1] Pfizer Global Res & Dev, Ann Arbor, MI USA
[2] Ann Arbor Labs, Ann Arbor, MI USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90541-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P50 / P50
页数：1
相关论文
共 50 条
  • [1] Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine
    Lal, Ritu
    Sukbuntherng, Juthamas
    Luo, Wendy
    Vicente, Virna
    Blumenthal, Robin
    Ho, Judy
    Cundy, Kenneth C.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (05) : 498 - 507
  • [2] Pharmacokinetic and dynamic effects of MDMA in humans.
    Harris, D
    Baggott, M
    Welm, S
    Jacob, P
    Mendelson, JH
    Jones, RT
    Mendelson, JE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 112 - 112
  • [3] ABT-335 does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.
    Zhu, T.
    Kelly, M. T.
    Hosmane, B. S.
    Chira, T. O.
    Sleep, D. J.
    Wan, K. X.
    Pradhan, R. S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S97 - S97
  • [4] COMPARATIVE PHARMACOKINETIC EVALUATION OF COMPRESSED NAPROXEN SUPPOSITORIES IN HUMANS
    SASTRY, MSP
    DIWAN, PV
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-2 (11): : 1209 - 1210
  • [5] Mechanism based pharmacokinetic/pharmacodynamic model of parathyroid hormone-calcium homeostasis in rats and humans.
    Abraham, A. K.
    Mager, D. E.
    Gao, X.
    Maurer, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S92 - S92
  • [6] Interaction of the RAAS and fibrinolytic system in humans.
    Brown, NJ
    Vaughan, DE
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 225A - 225A
  • [7] Clinical pharmacokinetic drug-interaction studies of XP13512, a novel transported prodrug of gabapentin, with naproxen and cimetidine
    Lal, Rita
    Sukbuntherng, Juthamas
    Luo, Wendy
    Elster, Paula G.
    Ho, Judy
    Blumenthal, Robin L.
    Cundy, Kenneth C.
    NEUROLOGY, 2008, 70 (11) : A295 - A295
  • [8] LACK OF A PHARMACOKINETIC INTERACTION BETWEEN PHENOBARBITONE AND GABAPENTIN
    HOOPER, WD
    KAVANAGH, MC
    HERKES, GK
    EADIE, MJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (02) : 171 - 174
  • [9] Lack of pharmacokinetic interaction between sumatriptan and naproxen
    Srinivasu, P
    Rambhau, D
    Rao, BR
    Rao, YM
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (01): : 99 - 104
  • [10] DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF CANAGLIFLOZIN IN HUMANS.
    Courtois, K.
    Rower, J. E.
    Bradshaw-Pierce, E. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S35 - S35
12345